ARCHIVES

Free Standing Cancer Center Firms Expanding Markets

This article is from The Cancer Letter archive.

Vol. 12 No. 08 | February 21, 1986

Download PDF Visit The Full Archive

Related Articles

Includes April issue of Business & Regulatory Report (8 pages).

May 2, 2003

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility

September 7, 1990

In Brief: FDA Seeks Applicants For Oncology Div. Head; Croce Wins Pasarow Award; CRI Honors Five

August 18, 1995

NCI To Merge Two Intramural Divisions To Form Center For Cancer Research.

January 12, 2001